Debt-to-equity of Quince Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Quince Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Quince Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 629%, a 368% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Quince Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 629% +495% +368% 30 Sep 2025
Q2 2025 341% +252% +283% 30 Jun 2025
Q1 2025 243% +191% +366% 31 Mar 2025
Q4 2024 173% +147% +562% 31 Dec 2024
Q3 2024 134% +131% +4456% 30 Sep 2024
Q2 2024 89% +86% +2401% 30 Jun 2024
Q1 2024 52% +48% +1081% 31 Mar 2024
Q4 2023 26% +20% +348% 31 Dec 2023
Q3 2023 3% -5.2% -64% 30 Sep 2023
Q2 2023 3.6% -6.1% -63% 30 Jun 2023
Q1 2023 4.4% -7.3% -62% 31 Mar 2023
Q4 2022 5.8% -6.3% -52% 31 Dec 2022
Q3 2022 8.2% -3.3% -29% 30 Sep 2022
Q2 2022 9.7% -1.1% -10% 30 Jun 2022
Q1 2022 12% +2.6% +29% 31 Mar 2022
Q4 2021 12% +4.4% +57% 31 Dec 2021
Q3 2021 11% +4.3% +59% 30 Sep 2021
Q2 2021 11% +4.5% +72% 30 Jun 2021
Q1 2021 9.1% +3.2% +54% 31 Mar 2021
Q4 2020 7.8% -0.03% -0.39% 31 Dec 2020
Q3 2020 7.2% -2.7% -27% 30 Sep 2020
Q2 2020 6.3% 30 Jun 2020
Q1 2020 5.9% 31 Mar 2020
Q4 2019 7.8% 31 Dec 2019
Q3 2019 9.9% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.